---
title: "ChemPartner PharmaTech Co., Ltd. (300149.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300149.SZ.md"
symbol: "300149.SZ"
name: "ChemPartner PharmaTech Co., Ltd."
industry: "Biotechnology"
datetime: "2026-05-20T12:02:05.790Z"
locales:
  - [en](https://longbridge.com/en/quote/300149.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300149.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300149.SZ.md)
---

# ChemPartner PharmaTech Co., Ltd. (300149.SZ)

## Company Overview

ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | CN Market |
| Website | [www.chempartner.com](https://www.chempartner.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.58)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 52 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.37% |  |
| Net Profit YoY | 94.14% |  |
| P/B Ratio | 3.64 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4679210404.54 |  |
| Revenue | 1142175963.49 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.00% | D |
| Profit Margin | 0.00% | D |
| Gross Margin | 22.15% | D |
| Revenue YoY | 14.37% | B |
| Net Profit YoY | 94.14% | A |
| Total Assets YoY | 2.67% | C |
| Net Assets YoY | 5.39% | C |
| Cash Flow Margin | -1947.25% | E |
| OCF YoY | 14.37% | B |
| Turnover | 0.00 | E |
| Gearing Ratio | 35.71% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - ChemPartner PharmaTech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "14.37%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "94.14%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4679210404.54",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1142175963.49",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "22.15%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "14.37%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "94.14%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.67%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.39%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-1947.25%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "14.37%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.00",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "35.71%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -410.22 | 80/81 | - | - | - |
| PB | 3.64 | 49/81 | 4.79 | 4.38 | 3.96 |
| PS (TTM) | 4.10 | 11/81 | 5.77 | 5.20 | 4.65 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sunshine Guojian Pharmaceutical (688336.SH) | A | A | B | A | B | A |
| 02 | AMOYTOP (688278.SH) | A | A | A | A | B | A |
| 03 | BeOne Medicines (688235.SH) | B | A | B | C | A | B |
| 04 | RemeGen (688331.SH) | A | A | C | C | B | B |
| 05 | InnoCare Pharma (688428.SH) | B | A | D | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300149.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300149.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300149.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300149.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**